Si-Bone (SIBN) Gains from Investment Securities (2017 - 2018)
Si-Bone (SIBN) posted quarterly Gains from Investment Securities of $145000.0 for Q4 2018, up 110.14% year-over-year from $69000.0 in Q4 2017, and down 68.27% quarter-over-quarter from $457000.0 in Q3 2018.
Si-Bone (SIBN) Gains from Investment Securities (2017 - 2018) Analysis & Trends
Si-Bone's Gains from Investment Securities history runs 2 years deep, the most recent figure standing at $145000.0 for Q4 2018.
- In Q4 2018, Gains from Investment Securities rose 110.14% year-over-year to $145000.0; the TTM figure through Sep 2019 stood at $145000.0 (down 80.67% YoY), while the FY2018 annual figure was $826000.0, up 597.59% from the prior year.
- Gains from Investment Securities for Q4 2018 stood at $145000.0, down from $457000.0 in the prior quarter.
- The five-year high for Gains from Investment Securities was $457000.0 in Q3 2018, with the low at $69000.0 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Si-Bone | 868.19 Mn | 722.25 Mn | 44.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 145,000.00 |
| Dec 31, 2018 | 145,000.00 |
| Sep 30, 2018 | 457,000.00 |
| Sep 30, 2018 | 457,000.00 |
| Jun 30, 2018 | 145,000.00 |
| Jun 30, 2018 | 145,000.00 |
| Mar 31, 2018 | 79,000.00 |
| Mar 31, 2018 | 79,000.00 |
| Dec 31, 2017 | 69,000.00 |
| Dec 31, 2017 | 69,000.00 |